JAMA names ten academic physicians and nurses to 2025 Editorial Fellowship Program

(Press-News.org) Chicago, January 23, 2025 —JAMA today announces a new cohort of ten academic physicians and nurses selected for the JAMA Editorial Fellowship Program, designed to engage early career clinical or health services researchers with JAMA’s editorial team to learn about editorial decision-making and enhance skills in scientific communication.

 

Fellows were chosen based on their demonstrated interest in medical publishing, medical education or research, or a career in academic medicine, as well as their communication skills and knowledge of medical research and study design.

 

The 2025 JAMA editorial fellows are:

 

Hannah Decker, MD, MAS, is a general surgery resident and National Clinician Scholar at UCSF. She is passionate about conducting high-quality research methodology to answer impactful questions and translating findings into practice via quality improvement and policy change to advance surgical equity. Her research has focused on surgical and oncologic care for people experiencing homelessness. 

 

Leah Estrada, PhD, RN, is an Assistant Professor in the Brookdale Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai and a Nurse Scientist at the Center for Nursing Research and Innovation in the Mount Sinai Health System. Her research focuses on improving palliative care services and delivery for Latino persons with dementia and their caregivers.

 

Robert Gallo, MD, is a hospitalist and Medical Informatics Research Fellow at the VA Palo Alto Health Care System and Stanford University. His research focuses on improving patient outcomes and supporting physicians in the inpatient setting, especially leveraging emerging technologies.

 

Adina Kern-Goldberger, MD, MPH, MSCE, is an Assistant Professor in the Division of Maternal-Fetal Medicine and the Department of Quantitative Health Sciences at the Cleveland Clinic Foundation/Cleveland Clinic Lerner College of Medicine at Case Western University. Her research interests are in obstetric healthcare delivery science, focused on comorbidity-based risk stratification in obstetric health services and on shared decision-making in preconception care.

 

David-Dan Nguyen, MDCM, MPH, is a urology resident at the University of Toronto in the Surgeon-Scientist Training Program. He is currently pursuing a Ph.D. in Clinical Epidemiology at the Institute of Health Policy, Management and Evaluation as a Vanier Scholar. His research interests are at the intersection of prostate cancer disparities, health policy, and machine learning.

 

Manan Pareek, MD, MSc, PhD, is a fellow in cardiovascular medicine at Copenhagen University Hospital, Rigshospitalet. He is the newly elected chair of the Danish Society of Cardiology Working Group for Acute Coronary Syndromes and a nucleus member of the Working Group for Thrombosis. He has served as an author on almost 30 national guideline documents and over 150 peer-reviewed articles. He is also the principal investigator of the ASPIRIN-C3, STATIN-C3, and DanRUSH trials.

 

Kathy Sliwinski, PhD, MBE, RN, is an AHRQ T-32 post-doctoral fellow in the Center for Health Services and Outcomes at the Feinberg School of Medicine at Northwestern University. Her research is at the intersection of health services, health policy, and health disparities, primarily focused on improving care delivery and clinical outcomes for patients with limited English proficiency.

 

Francesca Sperotto, MD, PhD, is a pediatric cardiologist and researcher at Boston Children’s Hospital, Harvard Medical School. Her research focuses on the intersection of advanced cardiac imaging, structural heart imaging, and cardiac critical care for pediatric patients with congenital and acquired heart disease.

 

Rebecca Tsevat, MD, MS, is a second-year fellow in the National Clinician Scholars Program at UCLA. Her research interests include partnering with schools to support youth with exposure to adverse childhood experiences and improving transitions of care for adolescents and young adults with chronic medical conditions.

 

Lachelle Weeks, MD, PhD, is a physician-scientist at Dana-Farber Cancer Institute and an Assistant Professor of Medicine at Harvard Medical School. She is the director of the CHIP Clinic in the Dana-Farber Centers for Early Detection, and the 2024-2027 Timmerman Traverse Clinical Investigator for the Damon Runyon Foundation for Cancer Research. Her research focuses on understanding features of clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of undetermined significance (CCUS) that impact the progression to overt myeloid diseases such as myelodysplastic syndrome and acute leukemia.

 

“Last year we piloted the fellowship, allowing applicants from a limited number of established programs. This year, we opened the program to any interested junior faculty member or research fellow,” said JAMA Deputy Editor Joseph Ross, MD, MHS, who leads the program.  “We could not have anticipated the enthusiasm for this opportunity, as more than 300 individuals applied. I am delighted to welcome our newest cohort.”

 

“This JAMA fellowship program is a complement to the fellowship programs across the Network, and to our growing JAMA editorial education programs,” said Kirsten Bibbins-Domingo, M.D., Ph.D., M.A.S., editor in chief of JAMA and the JAMA Network. “We are excited to launch these to support the many young scientists who are interested in publication and editorial decision-making.”

END